Pipeline

We develop disease-directed Lock-antibody for safer therapy
Besides providing platform service, PrecisemAb also utilizes antibody lock technology to develop potential Lock-antibody products in the area of autoimmune disease, surface marker, immunotherapy and antibody drug conjugate.

Pipeline

 
新版Pipeline.png
 

Industrial Applications

TOP